FROGENT: An End-to-End Full-process Drug Design Agent

• URL: http://arxiv.org/abs/2508.10760v1
• Date: Thu, 14 Aug 2025 15:45:53 GMT
• Title: FROGENT: An End-to-End Full-process Drug Design Agent
• Authors: Qihua Pan, Dong Xu, Jenna Xinyi Yao, Lijia Ma, Zexuan Zhu, Junkai Ji,
• Abstract summary: Powerful AI tools for drug discovery reside in isolated web apps, desktop programs, and code libraries.<n>To address this issue, a Full-pROcess druG dEsign ageNT, named FROGENT, has been proposed.<n>FROGENT utilizes a Large Language Model and the Model Context Protocol to integrate multiple dynamic biochemical databases, tool libraries, and task-specific AI models.
• Score: 19.025736969789566
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Powerful AI tools for drug discovery reside in isolated web apps, desktop programs, and code libraries. Such fragmentation forces scientists to manage incompatible interfaces and specialized scripts, which can be a cumbersome and repetitive process. To address this issue, a Full-pROcess druG dEsign ageNT, named FROGENT, has been proposed. Specifically, FROGENT utilizes a Large Language Model and the Model Context Protocol to integrate multiple dynamic biochemical databases, extensible tool libraries, and task-specific AI models. This agentic framework allows FROGENT to execute complicated drug discovery workflows dynamically, including component tasks such as target identification, molecule generation and retrosynthetic planning. FROGENT has been evaluated on eight benchmarks that cover various aspects of drug discovery, such as knowledge retrieval, property prediction, virtual screening, mechanistic analysis, molecular design, and synthesis. It was compared against six increasingly advanced ReAct-style agents that support code execution and literature searches. Empirical results demonstrated that FROGENT triples the best baseline performance in hit-finding and doubles it in interaction profiling, significantly outperforming both the open-source model Qwen3-32B and the commercial model GPT-4o. In addition, real-world cases have been utilized to validate the practicability and generalization of FROGENT. This development suggests that streamlining the agentic drug discovery pipeline can significantly enhance researcher productivity.

Related papers

• Agentic reinforcement learning empowers next-generation chemical language models for molecular design and synthesis [51.83339196548892]
  ChemCraft is a novel framework that decouples chemical reasoning from knowledge storage.<n>ChemCraft achieves superior performance with minimal inference costs.<n>This work establishes a cost-effective and privacy-preserving paradigm for AI-aided chemistry.
  arXiv  Detail & Related papers  (2026-01-25T04:23:34Z)
• AI Co-Scientist for Knowledge Synthesis in Medical Contexts: A Proof of Concept [0.0]
  We present an AI for scalable and transparent knowledge synthesis based on explicit formalization of Population, Intervention, Comparator, Outcome, and Study design (PICOS)<n>The platform integrates relational storage, vector-based semantic retrieval, and a Neo4j knowledge graph.<n>Results show that PICOS-aware and explainable natural language processing can improve the scalability, transparency, and efficiency of evidence synthesis.
  arXiv  Detail & Related papers  (2026-01-16T23:07:58Z)
• ReACT-Drug: Reaction-Template Guided Reinforcement Learning for de novo Drug Design [0.34155322317700576]
  We introduce bfReACT-Drug, a fully integrated, target-agnostic molecular design framework based on Reinforcement Learning.<n>This architecture highlights the potential of integrating structural biology, deep representation learning, and chemical rules to automate and accelerate rational drug design.
  arXiv  Detail & Related papers  (2025-12-24T05:29:35Z)
• Simple Agents Outperform Experts in Biomedical Imaging Workflow Optimization [69.36509281190662]
  Adapting production-level computer vision tools to bespoke scientific datasets is a critical "last mile" bottleneck.<n>We consider using AI agents to automate this manual coding, and focus on the open question of optimal agent design.<n>We demonstrate that a simple agent framework consistently generates adaptation code that outperforms human-expert solutions.
  arXiv  Detail & Related papers  (2025-12-02T18:42:26Z)
• FRAGMENTA: End-to-end Fragmentation-based Generative Model with Agentic Tuning for Drug Lead Optimization [1.5866079116942815]
  FRAGMENTA is an end-to-end framework for drug lead optimization.<n>It includes a novel generative model that reframes fragmentation as a "vocabulary selection" problem.<n>It also includes an agentic AI system that refines objectives via conversational feedback from domain experts.
  arXiv  Detail & Related papers  (2025-11-25T17:17:54Z)
• DrugMCTS: a drug repurposing framework combining multi-agent, RAG and Monte Carlo Tree Search [10.123162419093973]
  DrugMCTS is a novel framework that integrates RAG, multi-agent collaboration, and Monte Carlo Tree Search for drug repositioning.<n>It employs five specialized agents tasked with retrieving and analyzing molecular and protein information, thereby enabling structured and iterative reasoning.<n>Our results highlight the importance of structured reasoning, agent-based collaboration, and feedback-driven search mechanisms.
  arXiv  Detail & Related papers  (2025-07-10T04:39:55Z)
• ChemActor: Enhancing Automated Extraction of Chemical Synthesis Actions with LLM-Generated Data [53.78763789036172]
  We present ChemActor, a fully fine-tuned large language model (LLM) as a chemical executor to convert between unstructured experimental procedures and structured action sequences.<n>This framework integrates a data selection module that selects data based on distribution divergence, with a general-purpose LLM, to generate machine-executable actions from a single molecule input.<n>Experiments on reaction-to-description (R2D) and description-to-action (D2A) tasks demonstrate that ChemActor achieves state-of-the-art performance, outperforming the baseline model by 10%.
  arXiv  Detail & Related papers  (2025-06-30T05:11:19Z)
• DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery [54.79763887844838]
  Large language models (LLMs) integrated with autonomous agents hold significant potential for advancing scientific discovery through automated reasoning and task execution.<n>We introduce DrugPilot, a LLM-based agent system with a parameterized reasoning architecture designed for end-to-end scientific in drug discovery.<n>DrugPilot significantly outperforms state-of-the-art agents such as ReAct and LoT, achieving task completion rates of 98.0%, 93.5%, and 64.0% for simple, multi-tool, and multi-turn scenarios, respectively.
  arXiv  Detail & Related papers  (2025-05-20T05:18:15Z)
• ChemAgent: Self-updating Library in Large Language Models Improves Chemical Reasoning [64.2106664137118]
  ChemAgent is a novel framework designed to improve the performance of large language models (LLMs)<n>It is developed by decomposing chemical tasks into sub-tasks and compiling these sub-tasks into a structured collection that can be referenced for future queries.<n>When presented with a new problem, ChemAgent retrieves and refines pertinent information from the library, which we call memory.
  arXiv  Detail & Related papers  (2025-01-11T17:10:30Z)
• ACEGEN: Reinforcement learning of generative chemical agents for drug discovery [4.966722586536789]
  ACEGEN is a comprehensive and streamlined toolkit for generative drug design. TorchRL is a modern RL library that offers thoroughly tested reusable components. We show examples of ACEGEN applied in multiple drug discovery case studies.
  arXiv  Detail & Related papers  (2024-05-07T20:30:14Z)
• Chemist-X: Large Language Model-empowered Agent for Reaction Condition Recommendation in Chemical Synthesis [55.30328162764292]
  Chemist-X is a comprehensive AI agent that automates the reaction condition optimization (RCO) task in chemical synthesis.<n>The agent uses retrieval-augmented generation (RAG) technology and AI-controlled wet-lab experiment executions.<n>Results of our automatic wet-lab experiments, achieved by fully LLM-supervised end-to-end operation with no human in the lope, prove Chemist-X's ability in self-driving laboratories.
  arXiv  Detail & Related papers  (2023-11-16T01:21:33Z)
• CorpusBrain: Pre-train a Generative Retrieval Model for Knowledge-Intensive Language Tasks [62.22920673080208]
  Single-step generative model can dramatically simplify the search process and be optimized in end-to-end manner. We name the pre-trained generative retrieval model as CorpusBrain as all information about the corpus is encoded in its parameters without the need of constructing additional index.
  arXiv  Detail & Related papers  (2022-08-16T10:22:49Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.